Browsing Tag
da Vinci 5
2 posts
Why CONMED’s (NYSE: CNMD) reported sale review could reset the medtech value debate after Q2
CONMED’s sale speculation, Q2 results and AirSeal update put CNMD back in focus. Read how medtech M&A interest could reshape its turnaround story.
Intuitive Surgical (NASDAQ: ISRG) beats on every Q2 metric but stock falls 10% as guidance holds firm
Intuitive Surgical beat Q2 estimates with $2.89B revenue and $2.80 non-GAAP EPS, but ISRG fell ~10% after hours as procedure guidance stayed at 13.5%–15.5%.